table of content
1 Introduction to Research & Analysis Reports
1.1 Companion Cancer Diagnostics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Companion Cancer Diagnostics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Companion Cancer Diagnostics Overall Market Size
2.1 Global Companion Cancer Diagnostics Market Size: 2022 VS 2030
2.2 Global Companion Cancer Diagnostics Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Companion Cancer Diagnostics Players in Global Market
3.2 Top Global Companion Cancer Diagnostics Companies Ranked by Revenue
3.3 Global Companion Cancer Diagnostics Revenue by Companies
3.4 Top 3 and Top 5 Companion Cancer Diagnostics Companies in Global Market, by Revenue in 2022
3.5 Global Companies Companion Cancer Diagnostics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Companion Cancer Diagnostics Players in Global Market
3.6.1 List of Global Tier 1 Companion Cancer Diagnostics Companies
3.6.2 List of Global Tier 2 and Tier 3 Companion Cancer Diagnostics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Companion Cancer Diagnostics Market Size Markets, 2022 & 2030
4.1.2 Breast Cancer
4.1.3 Lung Cancer
4.1.4 Colorectal Cancer
4.1.5 Melanoma
4.1.6 Gastric Cancer
4.2 By Type - Global Companion Cancer Diagnostics Revenue & Forecasts
4.2.1 By Type - Global Companion Cancer Diagnostics Revenue, 2018-2023
4.2.2 By Type - Global Companion Cancer Diagnostics Revenue, 2024-2030
4.2.3 By Type - Global Companion Cancer Diagnostics Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Companion Cancer Diagnostics Market Size, 2022 & 2030
5.1.2 Pharmaceutical & Biopharmaceutical Companies
5.1.3 Reference Laboratories
5.1.4 CROs
5.1.5 Others
5.2 By Application - Global Companion Cancer Diagnostics Revenue & Forecasts
5.2.1 By Application - Global Companion Cancer Diagnostics Revenue, 2018-2023
5.2.2 By Application - Global Companion Cancer Diagnostics Revenue, 2024-2030
5.2.3 By Application - Global Companion Cancer Diagnostics Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Companion Cancer Diagnostics Market Size, 2022 & 2030
6.2 By Region - Global Companion Cancer Diagnostics Revenue & Forecasts
6.2.1 By Region - Global Companion Cancer Diagnostics Revenue, 2018-2023
6.2.2 By Region - Global Companion Cancer Diagnostics Revenue, 2024-2030
6.2.3 By Region - Global Companion Cancer Diagnostics Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Companion Cancer Diagnostics Revenue, 2018-2030
6.3.2 US Companion Cancer Diagnostics Market Size, 2018-2030
6.3.3 Canada Companion Cancer Diagnostics Market Size, 2018-2030
6.3.4 Mexico Companion Cancer Diagnostics Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Companion Cancer Diagnostics Revenue, 2018-2030
6.4.2 Germany Companion Cancer Diagnostics Market Size, 2018-2030
6.4.3 France Companion Cancer Diagnostics Market Size, 2018-2030
6.4.4 U.K. Companion Cancer Diagnostics Market Size, 2018-2030
6.4.5 Italy Companion Cancer Diagnostics Market Size, 2018-2030
6.4.6 Russia Companion Cancer Diagnostics Market Size, 2018-2030
6.4.7 Nordic Countries Companion Cancer Diagnostics Market Size, 2018-2030
6.4.8 Benelux Companion Cancer Diagnostics Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Companion Cancer Diagnostics Revenue, 2018-2030
6.5.2 China Companion Cancer Diagnostics Market Size, 2018-2030
6.5.3 Japan Companion Cancer Diagnostics Market Size, 2018-2030
6.5.4 South Korea Companion Cancer Diagnostics Market Size, 2018-2030
6.5.5 Southeast Asia Companion Cancer Diagnostics Market Size, 2018-2030
6.5.6 India Companion Cancer Diagnostics Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Companion Cancer Diagnostics Revenue, 2018-2030
6.6.2 Brazil Companion Cancer Diagnostics Market Size, 2018-2030
6.6.3 Argentina Companion Cancer Diagnostics Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Companion Cancer Diagnostics Revenue, 2018-2030
6.7.2 Turkey Companion Cancer Diagnostics Market Size, 2018-2030
6.7.3 Israel Companion Cancer Diagnostics Market Size, 2018-2030
6.7.4 Saudi Arabia Companion Cancer Diagnostics Market Size, 2018-2030
6.7.5 UAE Companion Cancer Diagnostics Market Size, 2018-2030
7 Companion Cancer Diagnostics Companies Profiles
7.1 F. Hoffmann-La Roche
7.1.1 F. Hoffmann-La Roche Company Summary
7.1.2 F. Hoffmann-La Roche Business Overview
7.1.3 F. Hoffmann-La Roche Companion Cancer Diagnostics Major Product Offerings
7.1.4 F. Hoffmann-La Roche Companion Cancer Diagnostics Revenue in Global Market (2018-2023)
7.1.5 F. Hoffmann-La Roche Key News & Latest Developments
7.2 Agilent Technologies
7.2.1 Agilent Technologies Company Summary
7.2.2 Agilent Technologies Business Overview
7.2.3 Agilent Technologies Companion Cancer Diagnostics Major Product Offerings
7.2.4 Agilent Technologies Companion Cancer Diagnostics Revenue in Global Market (2018-2023)
7.2.5 Agilent Technologies Key News & Latest Developments
7.3 QIAGEN
7.3.1 QIAGEN Company Summary
7.3.2 QIAGEN Business Overview
7.3.3 QIAGEN Companion Cancer Diagnostics Major Product Offerings
7.3.4 QIAGEN Companion Cancer Diagnostics Revenue in Global Market (2018-2023)
7.3.5 QIAGEN Key News & Latest Developments
7.4 Abbott Laboratories
7.4.1 Abbott Laboratories Company Summary
7.4.2 Abbott Laboratories Business Overview
7.4.3 Abbott Laboratories Companion Cancer Diagnostics Major Product Offerings
7.4.4 Abbott Laboratories Companion Cancer Diagnostics Revenue in Global Market (2018-2023)
7.4.5 Abbott Laboratories Key News & Latest Developments
7.5 Almac Group
7.5.1 Almac Group Company Summary
7.5.2 Almac Group Business Overview
7.5.3 Almac Group Companion Cancer Diagnostics Major Product Offerings
7.5.4 Almac Group Companion Cancer Diagnostics Revenue in Global Market (2018-2023)
7.5.5 Almac Group Key News & Latest Developments
7.6 Danaher Corporation
7.6.1 Danaher Corporation Company Summary
7.6.2 Danaher Corporation Business Overview
7.6.3 Danaher Corporation Companion Cancer Diagnostics Major Product Offerings
7.6.4 Danaher Corporation Companion Cancer Diagnostics Revenue in Global Market (2018-2023)
7.6.5 Danaher Corporation Key News & Latest Developments
7.7 bioM?rieuxSA
7.7.1 bioM?rieuxSA Company Summary
7.7.2 bioM?rieuxSA Business Overview
7.7.3 bioM?rieuxSA Companion Cancer Diagnostics Major Product Offerings
7.7.4 bioM?rieuxSA Companion Cancer Diagnostics Revenue in Global Market (2018-2023)
7.7.5 bioM?rieuxSA Key News & Latest Developments
7.8 Myriad Genetics
7.8.1 Myriad Genetics Company Summary
7.8.2 Myriad Genetics Business Overview
7.8.3 Myriad Genetics Companion Cancer Diagnostics Major Product Offerings
7.8.4 Myriad Genetics Companion Cancer Diagnostics Revenue in Global Market (2018-2023)
7.8.5 Myriad Genetics Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
